These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33722749)

  • 1. The role of innate immunity in myasthenia gravis.
    Zhao R; Luo S; Zhao C
    Autoimmun Rev; 2021 May; 20(5):102800. PubMed ID: 33722749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of myasthenia gravis: innate immunity signature in pathological thymus.
    Cavalcante P; Cufi P; Mantegazza R; Berrih-Aknin S; Bernasconi P; Le Panse R
    Autoimmun Rev; 2013 Jul; 12(9):863-74. PubMed ID: 23535157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.
    Bortone F; Scandiffio L; Marcuzzo S; Bonanno S; Frangiamore R; Motta T; Antozzi C; Mantegazza R; Cavalcante P; Bernasconi P
    Front Immunol; 2020; 11():142. PubMed ID: 32210951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
    Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
    Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
    Cavalcante P; Barzago C; Baggi F; Antozzi C; Maggi L; Mantegazza R; Bernasconi P
    Ann N Y Acad Sci; 2018 Feb; 1413(1):11-24. PubMed ID: 29363775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymus involvement in early-onset myasthenia gravis.
    Cron MA; Maillard S; Villegas J; Truffault F; Sudres M; Dragin N; Berrih-Aknin S; Le Panse R
    Ann N Y Acad Sci; 2018 Jan; 1412(1):137-145. PubMed ID: 29125185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.
    Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S
    Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia Gravis: An Acquired Interferonopathy?
    Payet CA; You A; Fayet OM; Dragin N; Berrih-Aknin S; Le Panse R
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor.
    Vrolix K; Fraussen J; Losen M; Stevens J; Lazaridis K; Molenaar PC; Somers V; Bracho MA; Le Panse R; Stinissen P; Berrih-Aknin S; Maessen JG; Van Garsse L; Buurman WA; Tzartos SJ; De Baets MH; Martinez-Martinez P
    J Autoimmun; 2014 Aug; 52():101-12. PubMed ID: 24439114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immunity in myasthenia gravis thymus: pathogenic effects of Toll-like receptor 4 signaling on autoimmunity.
    Cordiglieri C; Marolda R; Franzi S; Cappelletti C; Giardina C; Motta T; Baggi F; Bernasconi P; Mantegazza R; Cavalcante P
    J Autoimmun; 2014 Aug; 52():74-89. PubMed ID: 24397961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells.
    Verdier J; Fayet OM; Hemery E; Truffault F; Pinzón N; Demeret S; Behin A; Fadel E; Guihaire J; Corneau A; Blanc C; Berrih-Aknin S; Le Panse R
    Front Immunol; 2023; 14():1083218. PubMed ID: 36793723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thymus and myasthenia gravis.
    Ragheb S; Lisak RP
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the research on immunopathogenesis of myasthenia gravis].
    Zieliński M; Kuzdzał J; Soja J; Szlubowski A
    Neurol Neurochir Pol; 2003; 37(5):1085-94. PubMed ID: 15174254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of double-stranded RNA signaling in the etiology of autoimmune myasthenia gravis.
    Cufi P; Dragin N; Weiss JM; Martinez-Martinez P; De Baets MH; Roussin R; Fadel E; Berrih-Aknin S; Le Panse R
    Ann Neurol; 2013 Feb; 73(2):281-93. PubMed ID: 23280437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
    Beecher G; Putko BN; Wagner AN; Siddiqi ZA
    Drugs; 2019 Mar; 79(4):353-364. PubMed ID: 30762205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.